Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 20/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7870830 | 1.00 | CCR5 (0.82) | CCR5 | |
| SCHEMBL7870825 | 1.00 | CCR5 (0.82) | CCR5 | |
| SCHEMBL7874891 | 0.96 | CCR5 (0.76) | CCR5 | |
| SCHEMBL7869904 | 0.94 | CCR5 (0.73) | CCR5 | |
| SCHEMBL7863001 | 0.93 | CCR5 (0.71) | CCR5 | |
| SCHEMBL7868401 | 0.93 | CCR5 (0.71) | CCR5 | |
| SCHEMBL7863002 | 0.93 | CCR5 (0.71) | CCR5 | |
| SCHEMBL7874889 | 0.93 | CCR5 (0.71) | CCR5 | |
| SCHEMBL7868503 | 0.93 | CCR5 (0.71) | CCR5 | |
| SCHEMBL7869695 | 0.92 | CCR5 (0.69) | CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6303593-B1 | FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS | MERCK & CO., INC. | 2001-10-16 | — | — | US | claimed |
| US-6303593-B1 | FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS | MERCK & CO., INC. | 2001-10-16 | — | — | US | disclosed |